This study is testing a device called a Biophotonizer for people with brain disorders like Alzheimer's disease, dementia, Parkinson's disease, and traumatic brain injury. The Biophotonizer creates a strong biophoton field, which researchers believe helps the body heal itself. You might be able to join if you are at least 18 years old, have a diagnosed brain disorder, and have a caregiver who can support your involvement. The study will look at how the Biophotonizer impacts your overall quality of life and your thinking abilities (cognitive capacity) over 2 to 4 weeks. This study is trying to confirm earlier findings that suggested this therapy was safe and helpful.

Study design

This is a randomized, triple-blinded, placebo-controlled study involving about 80 participants. This means participants are randomly assigned to receive either the Biophotonizer or a placebo device, and neither you, your caregiver, nor the study staff will know which you are receiving at first.

What's involved

You will live in a hotel-like research center for 4 to 6 weeks. You will use a study device for at least 8 hours every night during sleep for the first 2 weeks, and potentially longer.

Compensation

Not stated in the trial record.

Follow-up

Your overall life quality and cognitive capacity will be measured at 0-2 weeks and 0-4 weeks after starting the study treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.